Hjem › KOLS › Louisiana › Shreveport
Kliniske studier for KOLS i Shreveport, LA
5 studier for KOLS søker deltakere på steder i og rundt Shreveport (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
RekruttererFase 3
- Research Site, Shreveport
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
RekruttererFase 3
- Ochsner LSU Health Shreveport - Academic Medical Center- Site Number : 8400083, Shreveport
- Care Access - Shreveport - Youree Drive- Site Number : 8400007, Shreveport
STRIVE Post-Market Registry Study
RekruttererObservasjonsstudie
- LSU Health Shreveport, Shreveport
eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
RekruttererFase 3
- GSK Investigational Site, Shreveport
Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
RekruttererFase 3
- GSK Investigational Site, Shreveport
KOLS-studier i andre byer
- Philadelphia, PA23 studier
- Miami, FL18 studier
- Birmingham, AL17 studier
- Boston, MA17 studier
- Orlando, FL15 studier
- Houston, TX15 studier
- Baltimore, MD14 studier
- Chicago, IL14 studier
- Dallas, TX12 studier
- Pittsburgh, PA12 studier
- New York City, NY11 studier
- Ann Arbor, MI10 studier
Andre studier i Shreveport
- Brystkreft8 studier
- Endometriekreft7 studier
- Fedme7 studier
- Eggstokkreft7 studier
- Ikke-småcellet lungekreft6 studier
- Kreft (alle typer)5 studier
- Overvekt4 studier
- Multipelt myelom4 studier
- Hjertesvikt4 studier
- Kardiovaskulær sykdom4 studier
- Steatotisk leversykdom3 studier
- Tripelnegativ brystkreft3 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.